CLINICAL_TRIALS
trial_result
· 2019-02-21
Clinical Trial Update: Dose-finding and Pharmacokinetic Study of DpC, Administered Orally to Patients With Advanced Solid Tumors [Phase 1]
Summary
Phase 1 dose-finding and pharmacokinetic study of DpC in patients with advanced solid tumors has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Collaborative Medicinal Development Pty Limited | Conditions: Neoplasms | Phase 1 | Status: COMPLETED